TITLE

2009 - Percutaneous closure of the left atrial appendage was noninferior to warfarin in atrial fibrillation

AUTHOR(S)
Sobieraj-Teague, Magdalena; Eikelboom, John; Holmes, D. R.
PUB. DATE
November 2009
SOURCE
ACP Journal Club;11/17/2009, Vol. 151 Issue 5, p8
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information about a clinical trial which analyzes whether percutaneous closure of the left atrial appendage (LAA) in patients with nonvalvular atrial fibrillation, is equal to warfarin for preventing stroke. The study involved 707 patients of 18 years of age. The results show that warfarin was as effective as percutaneous closure of the left atrial appendage for preventing stroke but it also increased adverse effects.
ACCESSION #
45665928

 

Related Articles

  • Antithrombotic treatment and atrial fibrillation: Warfarin reduces the risk of first time strokes by two thirds. Lowe, Gordon D.O. // BMJ: British Medical Journal (International Edition);12/12/92, Vol. 305 Issue 6867, p1445 

    Examines the use of antithrombotic treatment in preventing ischemic stroke in patients with atrial fibrillation. Association of atrial fibrillation with the mortality of patients; Application of warfarin as a prevention of stroke ; Efficacy of warfarin.

  • New Alternative to Warfarin May Help Reduce Stroke Risk in Patients With AF. Mitka, Mike // JAMA: Journal of the American Medical Association;1/5/2011, Vol. 305 Issue 1, p25 

    The article discusses the findings of the Stroke Prevention Using the Oral Direct Factor Xa Inhibitor Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation (ROCKET AF) trial presented during the Scientific Sessions of the American Heart Association (AHA) meeting...

  • Independent Nurse: Dabigatran 'could replace warfarin' in AF. Tanday, Sanjay // GP: General Practitioner;9/11/2009, p8 

    The article reports that according to the RELY trial, presented at the European Society of Cardiology Congress, the thrombin inhibitor dabigatran is as effective as warfarin for preventing stroke in patients with atrial fibrillation (AF). It says that both the drugs are associated with the risk...

  • Registrar: MRCGP Exam Update - AF and anticoagulation. Newson, Louise // GP: General Practitioner;1/26/2007, p47 

    The article focuses on anticoagulation therapy for atrial fibrillation (AF). According to the author, AF increases the risk of stroke. The author asserts that the increase in risk of bleeding on taking warfarin is the reason for the reluctance of many patients with non-rheumatic AF to use it....

  • Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial. Oldgren, Jonas; Alings, Marco; Darius, Harald; Diener, Hans-Christoph; Eikelboom, John; Ezekowitz, Michael D.; Kamensky, Gabriel; Reilly, Paul A.; Sean Yang; Yusuf, Salim; Wallentin, Lars; Connolly, Stuart J. // Annals of Internal Medicine;11/15/2011, Vol. 155 Issue 10, p660 

    Background: CHADS2 is a simple, validated risk score for predicting the risk for stroke in patients with atrial fibrillation not treated with anticoagulants. There are sparse data on the risk for thrombotic and bleeding complications according to the CHADS2 score in patients receiving...

  • Warfarin underused in patients with AF. Raible, Eric // Cardiology Today;Nov2008, Vol. 11 Issue 11, p1 

    The article reports that inadequate levels of warfarin are being given to patients with atrial fibrillation (AF) in the outpatient setting in the U.S. Though warfarin reduces risk for stroke in patients with AF, researchers from the World Health Information Science Consultants and...

  • Anticoagulation for patients with atrial fibrillation and risk factors for stroke. Connolly, Stuart J // BMJ: British Medical Journal (International Edition);05/06/2000, Vol. 320 Issue 7244, p1219 

    Discusses the randomized trials of treatment with anticoagulants that consistently reported a reduction of the incidence of strokes with warfarin. Analysis of patients with atrial fibrillation; Factors that play a part in anticoagulation; Survey results regarding the use of aspirin in patients...

  • Rivaroxaban: Another Warfarin Replacement. Elliott, William T. // Infectious Disease Alert;Jan2011 Clinical Brief, p1 

    The article focuses on the Stroke Prevention Using the Oral Direct Factor Xa Inhibitor Rivaroxaban Compared With Warfarin in Patients with Nonvalvular Atrial Fibrillation (ROCKET AF) study. For the study, researchers examined more than 14,000 individuals diagnosed by atrial fibrillation and...

  • Warfarin Better for Atrial Fibrillation Patients.  // OB/GYN Clinical Alert;Aug2007, Vol. 24 Issue 4, p2 

    The article reports on the effectiveness of warfarin in preventing stroke in patients with nonvalvular atrial fibrillation according to the results of a meta-analysis. It found that warfarin and antiplatelet agents reduce stroke by 64% and 22%, respectively. It also noted that adjusted-dose...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics